Baxter Deutschland GmbH
A single plant registered with the FDA to make drugs for the US market. Below is where it is and the drugs whose FDA labels list this site as performing a manufacturing step — so if this plant has a problem, these are the products that could be affected.
- Country
- Germany
- Registered address
- Artur-Ladebeck-Str. 136, Bielefeld, 33647, Germany (DEU)
- Operations here
- api manufacture
- FDA identifiers
- FEI 3002806414 · DUNS 312520353
FDA inspection history
Outcomes of closed FDA inspections at this site (drug and biologic program areas).
- VAIDrug Quality Assurance2025-05-28
- VAIDrug Quality Assurance2022-11-11
- NAIDrug Quality Assurance2018-06-14
- VAIDrug Quality Assurance2016-01-22
- NAIDrug Quality Assurance2011-08-26
Drugs this plant is listed as making
6 distinct drugs across 15 products name this site in their FDA label.
- bendamustine hydrochlorideBaxter Healthcare Corporation
- CyclophosphamideBaxter Healthcare Corporation
- ifosfamidein shortageBaxter Healthcare Corporation
- MesnaBaxter Healthcare Company
Sources:the establishment's name, address, and country from FDA's Drug Establishments Current Registration Site (DECRS); the drug-to-facility links from DailyMed SPL drug labels, matched by the facility's DUNS number; inspection outcomes from the FDA Data Dashboard, matched by FEI; shortage status from FDA's drug shortage database. More on how this is built. Educational only.